Evidence map›Paper›PMID 18446450›Full record

ArticleEndocrine pathology2008

Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder.

Soraya Puente, Ana Velasco, Pilar Gallel, Judit Pallares, Luis Perez-Ruiz, Susana Ros, Javier Maravall, Xavier Matias-Guiu

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Endocrine pathology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Soraya PuenteDepartment of Pathology, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLLEIDA, Alcalde Rovira Roure 80, 25198 Lleida, Spain.
Ana Velasco
Pilar Gallel
Judit Pallares
Luis Perez-Ruiz
Susana Ros
Javier Maravall
Xavier Matias-Guiu
Hospital Universitari Arnau de Vilanova · ESUniversitat de Lleida · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small cell carcinomas may occur in the thyroid gland. Infrequently, they are primary tumors, and have been interpreted as variants of medullary thyroid carcinoma. However, the vast majority of small cell carcinomas involving the thyroid gland are metastatic tumors. In some cases, demonstration of the primary tumor is not easy. An example of a small cell carcinoma metastatic to the thyroid is presented in this report. The primary tumor was a small cell carcinoma that occurred as a minor component in a transitional carcinoma of the urinary bladder. The microscopical and immunohistochemical features of both tumors, in the thyroid and the bladder, were identical. Moreover, both tumors exhibited an identical mutation in p53, as well as similar loss of heterozygosity at 10q23 and RASSF1A promoter hypermethylation, clearly indicating that the bladder tumor was the site for the primary tumor of the patient.

Indexed as

AdenocarcinomaBase SequenceCarcinoma, Small CellCarcinoma, Transitional CellDNA MethylationDNA Mutational AnalysisHumansImmunohistochemistryLoss of HeterozygosityMaleMiddle AgedNeoplasms, Multiple PrimaryPromoter Regions, GeneticProstatic NeoplasmsThyroid NeoplasmsTumor Suppressor Protein p53RASSF1 protein, humanTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID18446450
OpenAlexW1978971317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.